SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about earnings call

17 Oct 2025 Evaluate
Gland Pharma has informed that the Earnings Call for Investors/Analysts will be held on Monday, November 3, 2025, at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the quarter and half year ended September 30, 2025. The details of the Earnings Call for Investors/Analysts are enclosed. The transcript and the audio recording of the Earnings Call will be made available on the Company’s website.

The above information is a part of company’s filings submitted to BSE.  

Gland Pharma Share Price

1739.10 -16.90 (-0.96%)
16-Apr-2026 15:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1231.95
Zydus Lifesciences 938.00
Lupin 2322.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×